A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects

NCT06175949 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease

Interventions

DRUG: HRS-7085 Tablets
DRUG: HRS-7085 simulant

Sponsor

Shandong Suncadia Medicine Co., Ltd.